Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.

Saved in:
Bibliographic Details
Title: Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.
Authors: Chen J; Department of Internal Medicine, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205-7199, USA., Li D, Schaefer RF, Mehta JL
Source: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2004 Oct; Vol. 44 (4), pp. 446-52.
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Print Cited Medium: Print ISSN: 0160-2446 (Print) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0160-2446
DOI:10.1097/01.fjc.0000140205.74180.3c